| Protocol No. | Title |
|---|---|
| 24-GI-135-AZ | Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection |
| IMGN853-0421/GOG-3078 | Mirvetuximab Soravtansine w/ Bevacizumab vs. Bevacizumab as Maintenance in Platinum-sensitive OVC |
| NCI-CIRB-10522-PMC | NCI-CIRB-10522-PMC: A Phase 1 Clinical Trial of CA-4948 in Combination with Gemcitabine and Nab-Paclitaxel in Metastatic or Unresectable Pancreatic Ductal Carcinoma |
| NCI-CIRB-EA8192 | Durvalumab and Chemo for Pts w/ High Grade Upper Tract Urothelial Cancer Prior to Nephroureterectomy |
| NCI-CIRB-EA8212 | NCI-CIRB-EA8212:A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive Bladder Cancer (BRIDGE) |
| NCI-CIRB-S1937 | Compare Eribulin w or w/o Chemo Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer |